Pharmacokinetic Principles Flashcards
6 cards from real Pharmacology practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 Pharmacokinetic Principles flashcards as text
A patient is administered an oral medication that undergoes significant first-pass metabolism. Which of the following statements accurately describes the consequence of this phenomenon?
Answer: The oral dose required to achieve a therapeutic effect will be higher than the intravenous dose.
First-pass metabolism occurs when a drug's concentration is greatly reduced before it reaches systemic circulation, primarily by the liver and gut wall. This reduction in bioavailability means a higher oral dose is needed to achieve the same therapeutic plasma concentration as a dose administered intravenously, which bypasses this effect entirely.
A drug has a very large apparent volume of distribution (Vd) of 400 L in a 70 kg adult. What does this indicate about the drug's distribution characteristics?
Answer: It is extensively distributed into tissues outside the plasma.
The apparent volume of distribution (Vd) is a theoretical volume that relates the amount of drug in the body to its concentration in the plasma. A large Vd (significantly exceeding total body water of ~42 L) indicates that the drug is not confined to the plasma and has extensively distributed into extravascular tissues and fluids. This is often a characteristic of lipophilic drugs that readily cross cell membranes.
A patient with end-stage renal disease requires a medication that is primarily eliminated unchanged by the kidneys. Which pharmacokinetic parameter will be most significantly altered in this patient?
Answer: Half-life
For a drug eliminated primarily by the kidneys, severe renal impairment will drastically decrease its clearance from the body. A decrease in clearance, with no change in the volume of distribution, will lead to a prolonged elimination half-life (t1/2). This means the drug will stay in the body for a longer period, necessitating dose adjustments to avoid toxicity.
Which of the following describes a key characteristic of zero-order elimination kinetics?
Answer: A constant amount of drug is eliminated per unit of time.
In zero-order kinetics, the elimination process is saturated, meaning a constant, fixed amount of drug is removed from the body per unit of time, regardless of the plasma concentration. This is in contrast to first-order kinetics, where a constant fraction of the drug is eliminated per unit of time.
Drug metabolism is often categorized into Phase I and Phase II reactions. Which of the following is a primary goal of Phase I reactions?
Answer: Introducing or exposing a functional group on the parent drug.
Phase I metabolic reactions, which include oxidation, reduction, and hydrolysis, typically introduce or unmask a functional group (e.g., -OH, -NH2, -SH) on the drug molecule. This transformation often makes the drug more polar and provides a site for subsequent Phase II conjugation reactions.
After approximately how many half-lives does a drug administered via continuous infusion reach a steady-state concentration in the plasma?
Answer: 4-5 half-lives
It is a widely accepted pharmacokinetic principle that a drug will reach approximately 94-97% of its steady-state concentration after 4 to 5 elimination half-lives. At steady state, the rate of drug administration is equal to the rate of elimination.